Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-077360
Filing Date
2026-07-13
Accepted
2026-07-13 07:46:16
Documents
2
Period of Report
2026-07-13

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0297771-6k_kamada.htm 6-K 11158
2 KAMADA HIGHLIGHTS CYTOGAM STUDY RESULTS PRESENTED AT THE 2026 ISHLT ANNUAL MEETI ea029777101ex99-1.htm EX-99.1 21545
  Complete submission text file 0001213900-26-077360.txt   33722
Mailing Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402
Business Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402 97289406472
KAMADA LTD (Filer) CIK: 0001567529 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35948 | Film No.: 261170016
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)